Investor Presentation
16
Investor presentation
First six months of 2022
Attractive capital allocation to shareholders
DKK
billion
50
40
40
Annual cash return to shareholders
Capital allocation
Novo NordiskⓇ
24
24
• Return of free cash flow through both share buy-backs and dividends
• For 2021, the total dividend per share increased 14.3% to DKK 10.40
(including interim dividend of DKK 3.50 per share paid in August 2021)
• For 2022, the interim dividend of DKK 4.25 per share will be paid in
August 2022
Ongoing DKK 24 billion share repurchase programme for 2022
30
17
15
20
20
20
20
10
8
7
8
10
10
16
12
13
14
0
2019
2020
2021
2022E¹
Dividend
Interim dividend
Share repurchase
1 For 2022, expected free cash flow is DKK 57-62 billion;
Note: Share repurchase programmes run for 12 months starting in February. The total programme may be reduced in size if significant business development opportunities arise during 2022View entire presentation